Found 20 matching trials
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers PHASE2 Background:
Patients with cancers of the blood and immune system often ben...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant PHASE1 Donor Lymphocyte Infusion (DLI) following salvage chemotherapy is the one o...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML PHASE1 The purpose of the study is to determine the safety of an investigational t...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Innate Donor Effector Allogeneic Lymphocyte Infusion After Stem Cell Transplantation: the IDEAL Trial PHASE2 The curative principle behind allogeneic hematopoietic stem cell transplant...
Show More Location
Copenhagen University Hospital, Rigshospitalet
Learn More & Join Trial
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT PHASE1 The primary objective of this proposal is to conduct the first-in-human ran...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors PHASE1 This study will assess the feasibility of utilizing a reduced intensity con...
Show More Location
Kenneth DeSantes., MD
Learn More & Join Trial
Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers PHASE1 In this study, haploidentical relatives of a patient with recurrent or meta...
Show More Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Safety Study of 5-Azacitidine and Standard Donor Lymphocyte Infusion (DLI) to Treat Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) Relapsing After Allogeneic Stem Cell Transplantation PHASE2 This open label phase-II trial evaluates hematological response of an addit...
Show More Location
Universitaetsklinik Heidelberg, Medizinische Klinik und Poliklinik V
Learn More & Join Trial
Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood PHASE1 The goal of this clinical research study is to learn if researchers can suc...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Donor Lymphocyte Infusion With Azacitidine to Prevent Hematologic Malignancy Relapse After Stem Cell Transplantation PHASE2 The goal of this study is to determine whether post-transplant consolidatio...
Show More Location
University of California San Francisco
Learn More & Join Trial